Option Care Health Valuation

Q: What is the Fair Price of OPCH * when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

OPCH * (MX$628.01) is trading below our estimate of [[fair value]] (MX$1116.18)

Is OPCH * undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

3/6

Valuation Score 3/6

Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of OPCH * when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: OPCH * (MX$628.01) is trading below our estimate of fair value (MX$1116.18)

Significantly Below Fair Value: OPCH * is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for OPCH *?

Other financial metrics that can be useful for relative valuation.

The above table shows the n/a ratio for OPCH *. This is calculated by dividing OPCH *'s market cap by their current preferred multiple.
What is OPCH *'s n/a Ratio?
n/a	0x
n/a	n/a
Market Cap	US$5.37b

OPCH * key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	1.4x
Enterprise Value/EBITDA	16.5x
PEG Ratio	2.3x

Price to Earnings Ratio vs Peers

How does OPCH *'s PE Ratio compare to its peers?

The above table shows the PE ratio for OPCH * vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PE	Estimated Growth	Market Cap
Peer Average	74.6x
CRVL CorVel	70.3x	n/a	US$5.5b
LALPATHLAB Dr. Lal PathLabs	71.4x	15.8%	₹272.6b
MCOV B Medicover	109.5x	38.6%	SEK 28.5b
600763 Topchoice Medical	47.1x	15.7%	CN¥23.8b
OPCH * Option Care Health	25.4x	10.9%	Mex$5.4b

Price-To-Earnings vs Peers: OPCH * is good value based on its Price-To-Earnings Ratio (25.4x) compared to the peer average (74.6x).

Price to Earnings Ratio vs Industry

How does OPCH *'s PE Ratio compare vs other companies in the Global Healthcare Industry?

0 Companies	Price / Earnings	Estimated Growth	Market Cap
Industry Avg.	n/a	27.7%
	n/a	n/a	n/a

Fetching data

0 Companies	Price / Earnings	Estimated Growth	Market Cap
Industry Avg.	n/a	27.7%
	n/a	n/a	n/a

No more companies

Price-To-Earnings vs Industry: OPCH * is expensive based on its Price-To-Earnings Ratio (25.4x) compared to the Global Healthcare industry average (23.2x).

Price to Earnings Ratio vs Fair Ratio

What is OPCH *'s PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

OPCH * PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio	25.4x
Fair PE Ratio	n/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate OPCH *'s Price-To-Earnings Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.